StockData
CNBX Pharmaceuticals Inc. logo

CNBX Pharmaceuticals Inc. (CNBX) stock

CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $197.79KP/E –Yield –

CNBX Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

CNBX Pharmaceuticals's market cap was $221.37K on Oct 19, 2026, against $221.59K a year earlier. Over the last 5 years it ranged from $17.74K to $2.36B, with a median of $230.22K.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$221.37K-0.1%
2025Dec 31, 2025$221.59K-3.8%
2024Dec 31, 2024$230.22K-28.3%
2023Dec 29, 2023$321.08K-86.1%
2022Dec 30, 2022$2.30M-99.8%
2021Dec 31, 2021$1.40B-58.5%
2020Dec 31, 2020$3.38B+70.9%
2019Dec 31, 2019$1.98B-53.3%
2018Dec 31, 2018$4.23B-83.7%
2017Dec 29, 2017$25.97B+194.8%
2016Dec 30, 2016$8.81B+1226.7%
2015Dec 31, 2015$663.86M-80.3%
2014Dec 31, 2014$3.37B+58852.5%
2013Dec 31, 2013$5.71M-58.8%
2012Dec 31, 2012$13.88M–

More CNBX Pharmaceuticals figures

See a number that looks wrong?